| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40fe729ed0443ad56925b597dd8a9bde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1fcaddec0f5d2cc418acc8c38f858c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_135c2a0552353186ad47f0d491ca52bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70671499f9a6485059bc2ad720d78fd5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2008-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_497c89442d1f8e79cbd19a59222f54dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34ebd4d6845f8eb373af3703c1a73285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2b21981763281e87c95fcb2cc07e4c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a185a88d66ca53bba020d1ecfda5d642 |
| publicationDate |
2010-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2155227-A1 |
| titleOfInvention |
New treatment for chemical substance addiction |
| abstract |
The present invention provides a method for the treatment of chemical substance abuse by selectively inhibiting ghrelin activity in humans comprising administering to a human in need thereof a therapeutically-effective amount of a ghrelin receptor ligand (GHS-RL). The ghrelin receptor ligand (GHS-RL) can be selected from the group consisting of a ghrelin receptor antagonist (GHS-RA), a ghrelin receptor inverse agonist (GHS-RIA), and a ghrelin receptor partial agonist (GHS-RPA). More specifically, the invention provides a method for treating alcohol related disorders in humans comprising administering to a human in need thereof a therapeutically-effective amount of a compound which is a ghrelin receptor ligand (GHS-RL), such as a ghrelin receptor antagonist (GHS-RA), a ghrelin receptor inverse agonist (GHS-RIA) and a ghrelin receptor partial agonist (GHS-RPA). |
| priorityDate |
2007-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |